Shiv Kumar Prajapati

942 total citations
18 papers, 567 citations indexed

About

Shiv Kumar Prajapati is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Shiv Kumar Prajapati has authored 18 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 4 papers in Biomaterials and 3 papers in Molecular Biology. Recurrent topics in Shiv Kumar Prajapati's work include Nanoparticle-Based Drug Delivery (4 papers), Advancements in Transdermal Drug Delivery (3 papers) and Advanced Drug Delivery Systems (3 papers). Shiv Kumar Prajapati is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Advancements in Transdermal Drug Delivery (3 papers) and Advanced Drug Delivery Systems (3 papers). Shiv Kumar Prajapati collaborates with scholars based in India, Russia and Saudi Arabia. Shiv Kumar Prajapati's co-authors include Ankit Jain, Aakanchha Jain, Sourabh Jain, Payal Kesharwani, Ashish Jain, Nishi Mody, Meenakshi Bajpai, Amrita Kumari, Rohit Singhal and Mithun Rudrapal and has published in prestigious journals such as Journal of Ethnopharmacology, RSC Advances and International Journal of Biological Macromolecules.

In The Last Decade

Shiv Kumar Prajapati

17 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiv Kumar Prajapati India 10 201 194 131 118 106 18 567
Eleonora Calzoni Italy 11 217 1.1× 177 0.9× 186 1.4× 102 0.9× 93 0.9× 32 593
S. Malathi India 10 199 1.0× 154 0.8× 186 1.4× 86 0.7× 131 1.2× 22 603
Taha Umair Wani India 15 249 1.2× 204 1.1× 158 1.2× 58 0.5× 120 1.1× 43 667
Khaled AbouAitah Egypt 15 206 1.0× 213 1.1× 124 0.9× 66 0.6× 159 1.5× 25 655
Federica De Gaetano Italy 17 174 0.9× 207 1.1× 147 1.1× 162 1.4× 210 2.0× 36 755
Anam Razzaq China 14 275 1.4× 232 1.2× 101 0.8× 74 0.6× 247 2.3× 33 749
Awaji Y. Safhi Saudi Arabia 12 162 0.8× 124 0.6× 143 1.1× 161 1.4× 71 0.7× 45 590
Sitah Alharthi Saudi Arabia 10 155 0.8× 126 0.6× 140 1.1× 99 0.8× 76 0.7× 26 488
Emmanuel Chekwube Ossai Nigeria 7 150 0.7× 165 0.9× 144 1.1× 96 0.8× 66 0.6× 16 528

Countries citing papers authored by Shiv Kumar Prajapati

Since Specialization
Citations

This map shows the geographic impact of Shiv Kumar Prajapati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiv Kumar Prajapati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiv Kumar Prajapati more than expected).

Fields of papers citing papers by Shiv Kumar Prajapati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiv Kumar Prajapati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiv Kumar Prajapati. The network helps show where Shiv Kumar Prajapati may publish in the future.

Co-authorship network of co-authors of Shiv Kumar Prajapati

This figure shows the co-authorship network connecting the top 25 collaborators of Shiv Kumar Prajapati. A scholar is included among the top collaborators of Shiv Kumar Prajapati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiv Kumar Prajapati. Shiv Kumar Prajapati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jain, Ankit, et al.. (2025). Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress. Journal of Biological Engineering. 19(1). 67–67.
2.
Prajapati, Shiv Kumar, Ankit Jain, & Meenakshi Bajpai. (2025). Lipid-based nanoformulations in onychomycosis therapy: addressing challenges of current therapies and advancing treatment. RSC Advances. 15(10). 7799–7825. 4 indexed citations
3.
Prajapati, Shiv Kumar, Ankit Jain, & Meenakshi Bajpai. (2024). Development and validation of the RP-HPLC method for quantification of tavaborole. Analytical Methods. 16(30). 5280–5287. 5 indexed citations
4.
Jain, Ankit, Ashok K. Shakya, Shiv Kumar Prajapati, et al.. (2024). An insight into pharmaceutical challenges with ionic liquids: where do we stand in transdermal delivery?. Frontiers in Bioengineering and Biotechnology. 12. 1454247–1454247. 8 indexed citations
5.
Prajapati, Shiv Kumar, et al.. (2023). Nano-formulated siRNA-based therapeutic approaches for cancer therapy. 1. 100006–100006. 30 indexed citations
6.
Prajapati, Shiv Kumar, Gaurav Mishra, Payal Kesharwani, et al.. (2022). An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations. Journal of Ethnopharmacology. 296. 115420–115420. 19 indexed citations
7.
Kesharwani, Payal, Shiv Kumar Prajapati, Swapnil Sharma, et al.. (2022). Biodegradable Nanogels for Dermal Applications: An Insight. Current Nanoscience. 19(4). 509–524. 4 indexed citations
8.
9.
Rudrapal, Mithun, Shiv Kumar Prajapati, Payal Kesharwani, et al.. (2022). Protective Effects of Diets Rich in Polyphenols in Cigarette Smoke (CS)-Induced Oxidative Damages and Associated Health Implications. Antioxidants. 11(7). 1217–1217. 34 indexed citations
10.
Kesharwani, Prashant, Manisha Singh, Shiv Kumar Prajapati, et al.. (2022). Recent Update on the Alzheimer's Disease Progression, Diagnosis andTreatment Approaches. Current Drug Targets. 23(10). 978–1001. 16 indexed citations
11.
Jain, Ankit, Shiv Kumar Prajapati, Madhavi Tripathi, Ashok M. Raichur, & Jagat R. Kanwar. (2021). Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights. Expert Review of Clinical Pharmacology. 14(6). 715–734. 4 indexed citations
12.
Sharma, Kanika, Payal Kesharwani, Shiv Kumar Prajapati, et al.. (2021). An Insight into Anticancer Bioactives from Punica granatum (Pomegranate). Anti-Cancer Agents in Medicinal Chemistry. 22(4). 694–702. 19 indexed citations
13.
Prajapati, Shiv Kumar, et al.. (2021). Application of Coatings with Smart Functions. Mini-Reviews in Organic Chemistry. 18(7). 943–960. 2 indexed citations
14.
Prajapati, Shiv Kumar, et al.. (2020). Biomedical applications and toxicities of carbon nanotubes. Drug and Chemical Toxicology. 45(1). 435–450. 94 indexed citations
15.
Jain, Ankit, Shiv Kumar Prajapati, Amrita Kumari, Nishi Mody, & Meenakshi Bajpai. (2020). Engineered nanosponges as versatile biodegradable carriers: An insight. Journal of Drug Delivery Science and Technology. 57. 101643–101643. 51 indexed citations
16.
Prajapati, Shiv Kumar, et al.. (2019). Biodegradable polymers and constructs: A novel approach in drug delivery. European Polymer Journal. 120. 109191–109191. 190 indexed citations
17.
Prajapati, Shiv Kumar, et al.. (2018). Hyaluronic acid conjugated multi-walled carbon nanotubes for colon cancer targeting. International Journal of Biological Macromolecules. 123. 691–703. 72 indexed citations
18.
Jain, Sonika, Shiv Kumar Prajapati, Shalini Jain, Sourabh Jain, & Aakanchha Jain. (2018). Propylene Glycol-Liposome for Anticoagulant Drug Delivery Through Skin. Journal of Bionanoscience. 12(5). 721–727. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleonora Calzoni Breakdown of academic impact, for papers by S. Malathi Breakdown of academic impact, for papers by Taha Umair Wani Breakdown of academic impact, for papers by Khaled AbouAitah Breakdown of academic impact, for papers by Federica De Gaetano Breakdown of academic impact, for papers by Anam Razzaq Breakdown of academic impact, for papers by Awaji Y. Safhi Breakdown of academic impact, for papers by Sitah Alharthi Breakdown of academic impact, for papers by Emmanuel Chekwube Ossai
Rankless by CCL
2026